
Todd Hankinson
Division Head, Pediatric Neurosurgery · University of Colorado School of Medicine
Credentials: · · · · ·
History
- Present
Pediatric Neurosurgery Division · University of Colorado School of Medicine
- Present
Pediatric Neurosurgery | Professor Division · University of Colorado School of Medicine
Research
Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors
eLife · 2017 · 152 citations
Acta Neuropathologica · 2018 · 140 citations
Neuro-Oncology · 2022 · 110 citations

44 papers

41 papers

38 papers

35 papers

33 papers

32 papers

26 papers
- MT
25 papers
Grants
- 2026–2028
Optimizing Pre-Clinical Models of Admantinomatous Craniopharyngioma
National Cancer Institute · R03
Contact PI · $156K · University of Colorado Denver
- 2019–2021
Advancing Treatment for Pediatric Craniopharyngioma (ATPC); in vivo Tocilizumab Measurement
National Cancer Institute · R03
Contact PI · $155.5K · University of Colorado Denver
- 2016–2019
National Cancer Institute · R03
Contact PI · $155.5K · University of Colorado Denver
Clinical trials
- 2021–2023
Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors
Principal investigator · Terminated
University of Colorado, Denver
- 2019–2030
Prospective Pilot Study Identifying Clinically Relevant Biological Targets for Medical Therapy
Principal investigator · Enrolling by invitation
University of Colorado, Denver
- 2023–2027
MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Study chair · Recruiting · Phase 2
Nationwide Children's Hospital
- 2022–2029
ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma
Study chair · Recruiting · Phase 2
Nationwide Children's Hospital




